Unsettled issues with oral antiplatelet therapy: which one? How much? How long?

Presentations available when logged in:

  • Prevalence and predictors of dual antiplatelet therapy non-compliance after DES placement: 1-year results from the XIENCE V USA study
  • Effect of shorter dual antiplatelet therapy on 1-year clinical outcomes after implantation of DES
  • Comparison of clinical efficacy and safety of clopidogrel resinate with clopidogrel bisulfate in patients undergoing PCI
  • Prasugrel versus clopidogrel in medically managed unstable angina/NSTEMI: insights from the TRILOGY ACS platelet substudy in angiographically triag...
  • Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the Resolute zotarolimus-eluting stent
  • Clinical outcomes with 6-month dual antiplatelet therapy after implantation of Biolimus-A9 drug-eluting coronary stents
  • Switching from clopidogrel to prasugrel in patients having coronary stent implantation
  • Comparison of clopidogrel and prasugrel in patients with unprotected left main disease treated with everolimus-eluting stents: insight from the Flo...